Search results for "Ejection fraction"

showing 10 items of 378 documents

Exercise echocardiography for the evaluation of patients after nonsurgical coronary artery revascularization.

1993

Objectives. The purpose of this study was to demonstrate the accuracy of stress echocardiography for detecting the progression of coronary artery disease after nonsurgical revascularization. Background. The expanding role of nonsurgical coronary revascularization procedures mandates the development of sensitive noninvasive techniques for tbe detection of recurrent ischemia. Methods. Bicycle stress echocardiography was performed in a series of 86 patients 6.5 ±1.3 months after a revascularization procedure. Seven patients were excluded from analysis because of poor echocardiographic image quality. Results. Digital analysis achieved a sensitivity of 83% for the entire group and a specificity …

Malemedicine.medical_specialtymedicine.medical_treatmentIschemiaInfarctionCoronary DiseaseConstriction PathologicRevascularizationSensitivity and SpecificityCoronary artery diseaseRecurrenceInternal medicineStress EchocardiographymedicineHumansMyocardial infarctionAngioplasty Balloon CoronaryEjection fractionbusiness.industryMiddle Agedmedicine.diseaseCoronary Vesselsmedicine.anatomical_structureEchocardiographyCardiologyExercise TestFemaleRadiologybusinessCardiology and Cardiovascular MedicineArteryJournal of the American College of Cardiology
researchProduct

Assessment of quality of care of patients with ST-segment elevation myocardial infarction

2020

Aims:The 2017 European Society of Cardiology guidelines for the management of ST-elevation myocardial infarction recommended assessing quality of care to establish measurable quality indicators in order to ensure that every ST-elevation myocardial infarction patient receives the best possible care. We investigated the quality indicators of healthcare services in Poland provided to ST-elevation myocardial infarction patients.Methods and results:The Polish Registry of Acute Coronary Syndromes is a nationwide, multicentre, prospective study of acute coronary syndrome patients in Poland. For the purpose of assessing quality indicators, we included 8279 patients from the Polish Registry of Acute…

Malemedicine.medical_specialtymedicine.medical_treatmentacute myocardial infarctionQuality indicatorshealthcare system performance030204 cardiovascular system & hematologyCoronary AngiographyCritical Care and Intensive Care MedicineElectrocardiography03 medical and health sciences0302 clinical medicineReperfusion therapyPatient Self-ReportRisk FactorsOutcome Assessment Health CareHumansMedicineST segmentProspective StudiesRegistries030212 general & internal medicineMyocardial infarctionQuality of careAgedQuality of Health CareEjection fractionbusiness.industryPercutaneous coronary interventionGeneral MedicineMiddle Agedmedicine.diseasemortalityHeart failureEmergency medicineST Elevation Myocardial InfarctionFemaleCardiology and Cardiovascular MedicinebusinessEuropean Heart Journal. Acute Cardiovascular Care
researchProduct

Long-term outcomes of percutaneous coronary interventions or coronary artery bypass grafting for left main coronary artery disease in octogenarians (…

2014

Percutaneous coronary intervention (PCI) with drug-eluting stents is an accepted alternative to surgery for the treatment of unprotected left main coronary artery (ULMCA) disease, but the long-term outcome in elderly patients is unclear. Aim of our study was to compare the clinical outcomes of octogenarians with ULMCA disease treated either with PCI with drug-eluting stents or coronary artery bypass grafting (CABG). The primary study end point was the composite of death, cerebrovascular accident, and myocardial infarction at follow-up. A total of 304 consecutive patients with ULMCA stenosis treated with PCI or CABG and aged 80 years were selected and analyzed in a large multinational regist…

Malemedicine.medical_treatmentMedizinCoronaryKaplan-Meier EstimateCoronary AngiographyCohort StudiesPostoperative Complications80 and overMyocardial infarctionHospital MortalityRegistriesSurvivorsAngioplasty Balloon CoronaryCoronary Artery BypassAged 80 and overEjection fractionHazard ratioAge FactorsAge Factors; Aged 80 and over; Angioplasty Balloon Coronary; Cohort Studies; Coronary Angiography; Coronary Artery Bypass; Coronary Stenosis; Coronary Vessels; Female; Geriatric Assessment; Hospital Mortality; Humans; Kaplan-Meier Estimate; Male; Percutaneous Coronary Intervention; Postoperative Complications; Prognosis; Propensity Score; Registries; Retrospective Studies; Risk Assessment; Survival Analysis; Survivors; Treatment Outcome; Drug-Eluting Stents; Cardiology and Cardiovascular MedicineDrug-Eluting StentsPrognosisCoronary Vesselssurgical procedures operativeTreatment OutcomeDrug-eluting stentCardiologyFemaleCardiology and Cardiovascular Medicinemedicine.medical_specialtyRevascularizationRisk AssessmentPercutaneous Coronary InterventionInternal medicineAngioplastymedicineHumanscardiovascular diseasesPropensity ScoreGeriatric AssessmentAgedRetrospective Studiesbusiness.industryAngioplastyCoronary StenosisPercutaneous coronary interventionmedicine.diseaseSurvival AnalysisSurgeryConventional PCIbusinessBalloon
researchProduct

Differential prognostic impact of type 2 diabetes mellitus in women and men with heart failure with preserved ejection fraction

2020

Introduction and objectives Type 2 diabetes mellitus (DM2) is a common comorbidity in patients with heart failure (HF) with preserved ejection fraction (HFpEF). Previous studies have shown that diabetic women are at higher risk of developing HF than men. However, the long-term prognosis of diabetic HFpEF patients by sex has not been extensively explored. In this study, we aimed to evaluate the differential impact of DM2 on all-cause mortality in men vs women with HFpEF after admission for acute HF. Methods We prospectively included 1019 consecutive HFpEF patients discharged after admission for acute HF in a single tertiary referral hospital. Multivariate Cox regression analysis was used to …

Malemusculoskeletal diseasesmedicine.medical_specialtyComorbidity030204 cardiovascular system & hematologydiiferencias entre sexos03 medical and health sciencesDiabetes mellitus0302 clinical medicineInterquartile rangeInternal medicineSex differencesRisk of mortalitymedicineHumansWomenMortalityAgedAged 80 and overHeart FailureEjection fractionProportional hazards modelbusiness.industryHazard ratioDiferencias entre sexosStroke VolumeMujeresGeneral MedicinePrognosisInsuficiencia cardiaca con fracción de eyección preservadamedicine.diseaseComorbidityHeart failure with preserved ejection fractionDiabetes Mellitus Type 2MortalidadCohortFemalebusinessHeart failure with preserved ejection fractionRevista Española de Cardiología (English Edition)
researchProduct

Overweight and obesity are associated with cardiac adverse structure remodeling in Chinese elderly with hypertension

2019

AbstractThere is limited information on the association of overweight and obesity with cardiac remodeling in elderly population. Therefore, we investigated whether overweight and obesity are associated with cardiac geometric structures and function in Chinese elderly. A total of 1183 hospitalized patients (aged 65–99 years) with primary hypertension were collected retrospectively in a cross-sectional study, and divided into underweight, normal weight, overweight and obesity patient groups according to their body mass index (BMI). Cardiac echocardiographic parameters were compared between the groups. BMI was 17.2 ± 1.2, 21.4 ± 1.2, 25.1 ± 1.2, 30.2 ± 2.6 kg/m2 in underweight, normal weight, …

MaleobesityCross-sectional studycardiac adverse structurelcsh:MedicineBlood Pressure030204 cardiovascular system & hematologyOverweightVentricular Function LeftBody Mass Index0302 clinical medicinekohonnut verenpaine030212 general & internal medicinelcsh:ScienceCardiac device therapyAged 80 and overMultidisciplinaryEjection fractionChinese elderlysydänylipainoEchocardiographyHypertensionCardiologyFemaleUnderweightmedicine.symptomikääntyneetmedicine.medical_specialtyhypertensionHeart VentriclesArticle03 medical and health sciencesInternal medicinemedicineoverweightHumansObesitysydäntauditAgedRetrospective Studiesbusiness.industrylcsh:Rnutritional and metabolic diseasesRetrospective cohort studyOverweightmedicine.diseaseObesityCross-Sectional StudiesBlood pressureMultivariate Analysislihavuuslcsh:QbusinessBody mass indexScientific Reports
researchProduct

Pathophysiological role of oxidative stress in systolic and diastolic heart failure and its therapeutic implications

2015

Abstract Systolic and diastolic myocardial dysfunction has been demonstrated to be associated with an activation of the circulating and local renin–angiotensin–aldosterone system (RAAS), and with a subsequent inappropriately increased production of reactive oxygen species (ROS). While, at low concentrations, ROS modulate important physiological functions through changes in cellular signalling and gene expression, overproduction of ROS may adversely alter cardiac mechanics, leading to further worsening of systolic and diastolic function. In addition, vascular endothelial dysfunction due to uncoupling of the nitric oxide synthase, activation of vascular and phagocytic membrane oxidases or mit…

Mitochondrial ROSmedicine.medical_specialtyXanthine OxidasePhosphodiesterase InhibitorsDiastoleAngiotensin-Converting Enzyme InhibitorsReviewmedicine.disease_causeNitric OxideCardiovascular SystemAntioxidantsInternal medicinemedicineHumansEndothelial dysfunctionHeart Failure DiastolicEjection fractionNitratesbusiness.industryDiastolic heart failureNADPH OxidasesStroke VolumeVitaminsHydralazinemedicine.diseaseHydralazineExercise TherapyMitochondriaOxidative StressHeart failureCardiologyDrug Therapy CombinationNitric Oxide SynthaseCardiology and Cardiovascular MedicinebusinessReactive Oxygen SpeciesOxidative stressmedicine.drugHeart Failure Systolic
researchProduct

Safety and activity of trastuzumab-containing therapies for the treatment of metastatic breast cancer: our long-term clinical experience (GOIM study).

2007

Background: Trastuzumab is widely used as the treatment of choice for HER2-positive metastatic breast cancer (MBC). Patients and methods: Seventy patients, median age 57 years and range 31-81 years, were included in our retrospective analysis with the aim to evaluate safety and activity of trastuzumab-containing therapies. Results: We observed for first-line treatment response rate (RR) 41%, stable disease (SD) 47% and time to progression (TTP) 8 months (range 1-44). Corresponding numbers for second line were RR 23%, SD 62% and (TTP) 9 months (range 3-23) and beyond second line RR 22%, SD 78% and (TTP) 9 months (range 4-19). Overall survival was 19.2 months (3-62 months). The median cumulat…

OncologyAdultmedicine.medical_specialtyDrug-Related Side Effects and Adverse Reactionscardiac safety clinical experience heavily pretreated women metastatic breast cancer retrospective analysis trastuzumabAntineoplastic AgentsBone NeoplasmsBreast NeoplasmsSoft Tissue NeoplasmsAntibodies Monoclonal HumanizedAsymptomaticMetastasisBreast cancerTrastuzumabcardiac safety; clinical experience; heavily pretreated women; metastatic breast cancer; retrospective analysis; trastuzumabInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansskin and connective tissue diseasesAdverse effectneoplasmsAgedRetrospective StudiesAged 80 and overEjection fractionbusiness.industryCumulative doseAntibodies MonoclonalHematologyMiddle AgedTrastuzumabmedicine.diseaseMetastatic breast cancerSurgeryTreatment OutcomeOncologyFemalemedicine.symptombusinessmedicine.drugAnnals of oncology : official journal of the European Society for Medical Oncology
researchProduct

Safety of trastuzumab, alone or in combination, in elderly patients with HER2-positive breast cancer: A 5-year case series.

2012

e11056 Background: Breast cancer (BC) is frequent in the elderly and is burdened by high recurrence and death rates, due mostly to undertreatment. Trastuzumab (T), in combination with chemotherapy (CT) or hormonotherapy (HT), is a well-established treatment strategy for early and advanced HER2-positive (HER2+) breast cancer, but has been poorly studied in the elderly setting due to its infrequency. The aim of our study is to assess the safety of T in elderly patients with HER2+ BC. Methods: Between 2005 and 2010, consecutive HER2+ breast cancer patients of ≥70 years of age referred to two oncology centers and that received T-based therapy were retrospectively reviewed. All patients were tr…

OncologyCancer ResearchSeries (stratigraphy)medicine.medical_specialtyChemotherapyEjection fractionbusiness.industryMortality ratemedicine.medical_treatmentGeriatric assessmentmedicine.diseaseBreast cancerOncologyTrastuzumabInternal medicineHER2 Positive Breast CancerMedicinebusinessmedicine.drugJournal of Clinical Oncology
researchProduct

Use of myocardial work for multiparametric detection of subclinical anthracycline cardiotoxicity in breast cancer patients

2021

Abstract Funding Acknowledgements Type of funding sources: None. Background The aim of our study was to assess subclinical cardiac effects of anthracyclines (ANTs) in women treated for breast cancer (BC). Methods We enrolled 46 female patients with BC undergoing adjuvant treatment with anthracycline-containing chemotherapy (CT) followed by taxane (paclitaxel/docetaxel).  Patients underwent physical examination, electrocardiogram (ECG) and standard transthoracic echocardiography (TTE) including evaluation of diastolic and systolic function, measured as left ventricular ejection fraction (LVEF), left ventricular global longitudinal strain (GLS) and myocardial work (MW) expressed as global wor…

Oncologymedicine.medical_specialtyCardiotoxicityEjection fractionAnthracyclinebusiness.industryGeneral Medicinemedicine.diseaseChemotherapy regimenBreast cancerDocetaxelInternal medicinemedicineRadiology Nuclear Medicine and imagingCardiology and Cardiovascular MedicineAdverse effectbusinessSubclinical infectionmedicine.drugEuropean Heart Journal - Cardiovascular Imaging
researchProduct

Meßfehlerschätzung bei der MR-tomographischen Volumetrie des linken Ventrikels mit Mehrschicht-Technik

1992

A multi-slice technique for MRT measurements of the left ventricular volume is much faster than the use of single-slice methods and is therefore better tolerated, leaving time for additional measurements. The end-diastolic left ventricular volume can be reliably measured by this method (123.3 +/- 13.5 ml vs. 124.1 +/- ml). The end-systolic volume is consistently overestimated by 23.7 +/- 18.3% compared with the reference value obtained by single slice measurements (47.9 +/- 8.9 ml vs 39.1 +/- 7.9 ml). Correspondingly, stroke volume and ejection fraction is underestimated on average by 10.6 +/- 9.7% and 10.6 +/- 7.6% respectively).

PhysicsObservational errorEjection fractionbusiness.industryStroke volumemedicine.anatomical_structureNuclear magnetic resonanceVolume (thermodynamics)VentriclemedicineEnd-diastolic volumeRadiology Nuclear Medicine and imagingMultisliceNuclear medicinebusinessEnd-systolic volumeRöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren
researchProduct